NDC50419-0188-15: GADOPENTETATE DEMIGLUMINE INJECT.
GADOPENTETATE DEMIGLUMINE INJECT. Key specifications include primary_container_type: VIAL, SINGLE DOSE, therapeutic_equivalent: MAGNEVIST BY BERLEX, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 20, primary_container_content_quantity: 15.000 MILLILITERS, active_medicament_medicinal_strength: 469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-373-1448, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | VIAL, SINGLE DOSE |
| therapeutic_equivalent | MAGNEVIST BY BERLEX |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 20 |
| primary_container_content_quantity | 15.000 MILLILITERS |
| active_medicament_medicinal_strength | 469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER |
| part_name_assigned_by_controlling_agency | GADOPENTETATE DEMIGLUMINE INJECTION USP 15ML VIAL 20S |
| NSN | 6505-01-373-1448 |
| THERAPEUTIC EQUIVALENT | MAGNEVIST BY BERLEX |
| PRIMARY CONTAINER CONTENT QUANTITY | 15.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | GADOPENTETATE DEMIGLUMINE INJECTION USP 15ML VIAL 20S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 20 |